Unique ID issued by UMIN | UMIN000028060 |
---|---|
Receipt number | R000032112 |
Scientific Title | Inhibition of liver cystogene |
Date of disclosure of the study information | 2017/10/01 |
Last modified on | 2019/03/15 09:14:45 |
Inhibition of liver cystogene
TVP for PKLD
Inhibition of liver cystogene
TVP for PKLD
Japan |
Polycystic kidney disease
Nephrology |
Others
NO
we assess the therapeutic value of tolvaptan for PLD in PKD patients
Efficacy
Changes in TLV
Changes in TKV, eGFR, and urinary osmorality
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Kidney volume>= 750ml
rate of Kidney volume increase >=5%/year
TLV>=2000cm^3
eGFR<15
Hypernatremia
Chronic liver injury
Patients who do not feel thirsty or have difficulty in ingesting water
Pregnant woman
do not obtain consent
Doctor judged inappropriate
150
1st name | Junichi |
Middle name | |
Last name | Hoshino |
Toranomon Hospital
Nephrology Center
1058470
2-2-2 Toranomon,Minato-ku,Tokyo-to
03-3588-1111
hoshino-ind@umin.ac.jp
1st name | Junichi |
Middle name | |
Last name | Hoshino |
Toranomon Hospital
Nephrology Center
1058470
2-2-2 Toranomon,Minato-ku,Tokyo-to
03-3588-1111
hoshino-ind@umin.ac.jp
Toranomon Hospital
Self funding
Otsuka Pharmaceutical Co. Ltd.
Other
Toranomon Hospital
2-2-2, Toranomon, Minato-ku
03-3588-1111
chiken-jim2@toranomon.gr.jp
NO
2017 | Year | 10 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2017 | Year | 07 | Month | 03 | Day |
2017 | Year | 10 | Month | 17 | Day |
2017 | Year | 10 | Month | 17 | Day |
2020 | Year | 03 | Month | 31 | Day |
none
2017 | Year | 07 | Month | 04 | Day |
2019 | Year | 03 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032112